Skip to main content
Top
Published in: BMC Nephrology 1/2018

Open Access 01-12-2018 | Research article

Single-marker and multi-marker approaches to appraise the relationships between biomarkers and microalbuminuria in Chinese middle-aged and elderly from communities: a cross-sectional analysis

Authors: Shihui Fu, Yi Guo, Zhao Zhang, Leiming Luo, Ping Ye

Published in: BMC Nephrology | Issue 1/2018

Login to get access

Abstract

Background

Analyzing the relationships between biomarkers representing distinct pathophysiologic pathways and microalbuminuria (MA) can strengthen the identifying ability for renal damage and illuminate previously unrecognized pathways for the pathogenesis of renal damage. The current analysis was to clarify the associations between biomarkers, including N-terminal prohormone of brain natriuretic peptide (NT-proBNP), high-sensitivity C-reactive protein (hsCRP), homocysteine and uric acid (UA), and MA in Chinese middle-aged and elderly from communities.

Methods

All 839 residents had complete set of these biomarkers and full assessment of MA.

Results

Prevalence of participants with MA was 13.5% (113 participants). Levels of age, systolic blood pressure (SBP), fasting blood glucose (FBG), homocysteine and NT-proBNP and proportion of cigarette smoking in participants with MA significantly exceeded those in participants without MA (p < 0.05 for all). In single-marker and multi-marker models of linear and logistic regression analyses, homocysteine and NT-proBNP levels (p < 0.05 for all) rather than hsCRP and UA levels (p > 0.05 for all) were statistically significant in relation to MA. Additionally, no matter which biomarker was directed at, levels of age, SBP and FBG and proportion of cigarette smoking had significant associations with MA. Homocysteine and NT-proBNP levels (p < 0.05 for all) rather than hsCRP and UA levels (p > 0.05 for all) had significant abilities to identify MA.

Conclusion

Both single-marker and multi-marker analyses confirmed that homocysteine and NT-proBNP were associated with MA in Chinese middle-aged and elderly from communities after adjustment for multiple confounders.
Literature
1.
go back to reference Singh M. The cardiorenal connection: new insights toward choice of revascularization. J Am Coll Cardiol. 2014;64:995–6.CrossRefPubMed Singh M. The cardiorenal connection: new insights toward choice of revascularization. J Am Coll Cardiol. 2014;64:995–6.CrossRefPubMed
3.
go back to reference Lawrence J, Bai S, Hung HM, O'Neill R. Regional treatment effects in studies of cardiorenal drugs: a summary of recent clinical trials. J Am Coll Cardiol. 2012;60:1117–8.CrossRefPubMed Lawrence J, Bai S, Hung HM, O'Neill R. Regional treatment effects in studies of cardiorenal drugs: a summary of recent clinical trials. J Am Coll Cardiol. 2012;60:1117–8.CrossRefPubMed
6.
go back to reference Resl M, Clodi M, Neuhold S, et al. Serum uric acid is related to cardiovascular events and correlates with N-terminal pro-Btype natriuretic peptide and albuminuria in patients with diabetes mellitus. Diabet Med. 2012;29:721–5.CrossRefPubMed Resl M, Clodi M, Neuhold S, et al. Serum uric acid is related to cardiovascular events and correlates with N-terminal pro-Btype natriuretic peptide and albuminuria in patients with diabetes mellitus. Diabet Med. 2012;29:721–5.CrossRefPubMed
7.
go back to reference de Jong PE, Curhan GC. Screening, monitoring, and treatment of albuminuria: Public health perspectives. J Am Soc Nephrol. 2006;17:2120–6.CrossRefPubMed de Jong PE, Curhan GC. Screening, monitoring, and treatment of albuminuria: Public health perspectives. J Am Soc Nephrol. 2006;17:2120–6.CrossRefPubMed
8.
go back to reference Yi S, Contreras G, Miller ER, Appel LJ, Astor BC. Correlates of Nterminal prohormone brain natriuretic peptides in African Americans with hypertensive chronic kidney disease: the African American study of kidney disease and hypertension. Am J Nephrol. 2009;29:292–8.CrossRefPubMed Yi S, Contreras G, Miller ER, Appel LJ, Astor BC. Correlates of Nterminal prohormone brain natriuretic peptides in African Americans with hypertensive chronic kidney disease: the African American study of kidney disease and hypertension. Am J Nephrol. 2009;29:292–8.CrossRefPubMed
9.
go back to reference Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17:2937–44.CrossRefPubMed Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17:2937–44.CrossRefPubMed
10.
go back to reference Hoogeveen EK, Kostense PJ, Jager A, et al. Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn study. Kidney Int. 1998;54:203–9.CrossRefPubMed Hoogeveen EK, Kostense PJ, Jager A, et al. Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn study. Kidney Int. 1998;54:203–9.CrossRefPubMed
11.
go back to reference Sabanayagam C, Shankar A. Association between plasma homocysteine and microalbuminuria in persons without hypertension, diabetes mellitus and cardiovascular disease. Clin Exp Nephrol. 2011;15:92–9.CrossRefPubMed Sabanayagam C, Shankar A. Association between plasma homocysteine and microalbuminuria in persons without hypertension, diabetes mellitus and cardiovascular disease. Clin Exp Nephrol. 2011;15:92–9.CrossRefPubMed
12.
go back to reference Li J, Shi M, Zhang H, et al. Relation of homocysteine to early nephropathy in patients with type 2 diabetes. Clin Nephrol. 2012;77:305–10.CrossRefPubMed Li J, Shi M, Zhang H, et al. Relation of homocysteine to early nephropathy in patients with type 2 diabetes. Clin Nephrol. 2012;77:305–10.CrossRefPubMed
13.
go back to reference Ninomiya T, Kiyohara Y, Kubo M, et al. Hyperhomocysteinemia and the development of chronic kidney disease in a general population: the Hisayama study. Am J Kidney Dis. 2004;44:437–45.CrossRefPubMed Ninomiya T, Kiyohara Y, Kubo M, et al. Hyperhomocysteinemia and the development of chronic kidney disease in a general population: the Hisayama study. Am J Kidney Dis. 2004;44:437–45.CrossRefPubMed
14.
go back to reference Tsai JC, Perrella MA, Yoshizumi M, et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci U S A. 1994;91:6369–73.CrossRefPubMedPubMedCentral Tsai JC, Perrella MA, Yoshizumi M, et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci U S A. 1994;91:6369–73.CrossRefPubMedPubMedCentral
15.
go back to reference Miliku K, Mesu A, Franco OH, et al. Maternal and fetal folate, vitamin B12, and homocysteine concentrations and childhood kidney outcomes. Am J Kidney Dis. 2017;69:521–30.CrossRefPubMedPubMedCentral Miliku K, Mesu A, Franco OH, et al. Maternal and fetal folate, vitamin B12, and homocysteine concentrations and childhood kidney outcomes. Am J Kidney Dis. 2017;69:521–30.CrossRefPubMedPubMedCentral
16.
go back to reference van Kimmenade RR, Januzzi JL Jr, Bakker JA, et al. Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide: A mechanistic study in hypertensive subjects. J Am Coll Cardiol. 2009;53:884–90.CrossRefPubMed van Kimmenade RR, Januzzi JL Jr, Bakker JA, et al. Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide: A mechanistic study in hypertensive subjects. J Am Coll Cardiol. 2009;53:884–90.CrossRefPubMed
17.
go back to reference Suganami T, Mukoyama M, Sugawara A, et al. Overexpression of brain natriuretic peptide in mice ameliorates immune-mediated renal injury. J Am Soc Nephrol. 2001;12:2652–63.PubMed Suganami T, Mukoyama M, Sugawara A, et al. Overexpression of brain natriuretic peptide in mice ameliorates immune-mediated renal injury. J Am Soc Nephrol. 2001;12:2652–63.PubMed
18.
go back to reference Makino H, Mukoyama M, Mori K, et al. Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice. Diabetologia. 2006;49:2514–24.CrossRefPubMed Makino H, Mukoyama M, Mori K, et al. Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice. Diabetologia. 2006;49:2514–24.CrossRefPubMed
19.
go back to reference Dieplinger B, Mueller T, Kollerits B, et al. Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD study. Kidney Int. 2009;75:408–14.CrossRefPubMed Dieplinger B, Mueller T, Kollerits B, et al. Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD study. Kidney Int. 2009;75:408–14.CrossRefPubMed
Metadata
Title
Single-marker and multi-marker approaches to appraise the relationships between biomarkers and microalbuminuria in Chinese middle-aged and elderly from communities: a cross-sectional analysis
Authors
Shihui Fu
Yi Guo
Zhao Zhang
Leiming Luo
Ping Ye
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2018
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-018-0888-3

Other articles of this Issue 1/2018

BMC Nephrology 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.